Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
9 studies found for:    Lymphocytopenia | Open Studies | NIH, U.S. Fed
Show Display Options
Download search resultsDownload the search results for:
Lymphocytopenia | Open Studies | NIH, U.S. Fed (9 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Conditions: Idiopathic CD4+ Lymphocytopenia;   Cryptococcal Meningitis;   Warts
Intervention:
2 Recruiting Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Condition: T-Lymphocytopenia, Idiopathic CD4-Positive
Intervention:
3 Recruiting Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Conditions: Graft vs Host Disease;   Healthy;   Lymphopenia
Intervention: Drug: G-CSF
4 Recruiting Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia
Condition: Malignant Neoplasms Brain
Interventions: Biological: RNA-loaded dendritic cell vaccine;   Drug: basiliximab
5 Recruiting Natural History Study of GATA2 Deficiency and Related Disorders
Conditions: Myelodysplasia;   Monocytopenia;   B Cell Lymphopenia;   NK Cell Deficiency;   Warts
Intervention:
6 Recruiting Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Radiation: photon beam radiation therapy;   Radiation: proton beam radiation therapy;   Drug: temozolomide;   Other: laboratory biomarker analysis
7 Not yet recruiting Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation
Conditions: Head and Neck Cancer;   HPV (Human Papillomavirus)-Associated Carcinoma;   Oropharyngeal
Intervention: Other: research blood draw  and tissue biopsy
8 Recruiting Participation in a Research Registry for Immune Disorders
Conditions: ADA-SCID;   Adenosine Deaminase Deficiency;   Wiskott- Aldrich Syndrome;   Primary Immunodeficiencies;   Severe Combined Immune Deficiency
Intervention:
9 Recruiting Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990
Condition: Wiskott-Aldrich Syndrome
Intervention:

Indicates status has not been verified in more than two years